O-20137 A novel volume-regulated anion channel inhibitor, YM-255693, prevents ischemia-induced arrhythmia in rats

The aim of this study is to evaluate a contribution of the volume-regulated anion channel (VRAC) to ischemia-induced arrhythmia. YM-255693, an isothiazol derivative, inhibited VRAC in hypotonic stimulus-induced taurine efflux assay in HeLa cells (IC50=0. 83μM) more potently than often-used VRAC bloc...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Pharmacological Sciences 2004, Vol.94 (suppl.1), p.108-108
Main Authors: Hiroshi Shibata, Tomo-oki Satoh, Tohru Ugawa, Hiroko Yanai-Inamura, Noriyuki Masuda, Wataru Uchida, Keiji Miyata
Format: Article
Language:Japanese
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 108
container_issue suppl.1
container_start_page 108
container_title Journal of Pharmacological Sciences
container_volume 94
creator Hiroshi Shibata
Tomo-oki Satoh
Tohru Ugawa
Hiroko Yanai-Inamura
Noriyuki Masuda
Wataru Uchida
Keiji Miyata
description The aim of this study is to evaluate a contribution of the volume-regulated anion channel (VRAC) to ischemia-induced arrhythmia. YM-255693, an isothiazol derivative, inhibited VRAC in hypotonic stimulus-induced taurine efflux assay in HeLa cells (IC50=0. 83μM) more potently than often-used VRAC blocker, DIDS or NPPB. In contrast, YM-255693 weakly inhibited Ca2+-activated and cAMP-activated Cl- channel in HTC cells (IC50=5. 9μM) and T84 cells (40% at 30μM), respectively. VRAC is reported to be involved in control of membrane potential in the ischemic condition in cardiac myocytes. YM-255693 was, therefore, tested in ischemia-induced arrhythmia models in vitro and in vivo. YM-255693 prevented coronary artery (LAD) ligation-induced ventricular arrhythmias in Langendorff-perfused rat hearts. Moreover, YM-255693 at 30mg/kg i. v. inhibited LAD ligation-induced ventricular arrhythmias in anesthetized rats. Our data suggest that VRAC contributes to the occurrence of ventricular arrhythmias, and that VRAC inhibitors such as YM-255693 constitute a new class of antiarrhythmic agents.
format article
fullrecord <record><control><sourceid>medicalonline</sourceid><recordid>TN_cdi_medicalonline_journals_cf6scien_2004_0094s1_392_0108_01081078088</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>cf6scien_2004_0094s1_392_0108_01081078088</sourcerecordid><originalsourceid>FETCH-medicalonline_journals_cf6scien_2004_0094s1_392_0108_010810780883</originalsourceid><addsrcrecordid>eNqtjEtOxDAQRLMAiRHMHXyAsdS283GWCPHZIDZsWFkep2fSyGmDnUTi9gTEEdhUSfX06qLaKVN30rbKXFX7UugIoK3Wqml21eeL1KBMJ24FpxWjWFNcJpQZz0v0Mw7CMyUWYfTMGyYe6Uhzygfx9ix107S9OYiPjCvyXASVMOJEXhIPS_ixcx6_5nGbNlVkP5eb6vLkY8H9X19Xjw_3r3dPcsKBgo-JIzG697Rk3rgLp7YEQnYaoHYAfV2UM712oMD-hoLOgrXm_56-AayNXmg</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>O-20137 A novel volume-regulated anion channel inhibitor, YM-255693, prevents ischemia-induced arrhythmia in rats</title><source>ScienceDirect®</source><creator>Hiroshi Shibata ; Tomo-oki Satoh ; Tohru Ugawa ; Hiroko Yanai-Inamura ; Noriyuki Masuda ; Wataru Uchida ; Keiji Miyata</creator><creatorcontrib>Hiroshi Shibata ; Tomo-oki Satoh ; Tohru Ugawa ; Hiroko Yanai-Inamura ; Noriyuki Masuda ; Wataru Uchida ; Keiji Miyata ; Research Coordination Dep ; Inst. for Drug Discovery Res ; Ltd ; Pharmacology Lab ; Yamanouchi Pharmaceutical Co ; Faculty of Agriculture ; Okayama Univ. The Grad. School of Natural Science and Technology ; Okayama Univ</creatorcontrib><description>The aim of this study is to evaluate a contribution of the volume-regulated anion channel (VRAC) to ischemia-induced arrhythmia. YM-255693, an isothiazol derivative, inhibited VRAC in hypotonic stimulus-induced taurine efflux assay in HeLa cells (IC50=0. 83μM) more potently than often-used VRAC blocker, DIDS or NPPB. In contrast, YM-255693 weakly inhibited Ca2+-activated and cAMP-activated Cl- channel in HTC cells (IC50=5. 9μM) and T84 cells (40% at 30μM), respectively. VRAC is reported to be involved in control of membrane potential in the ischemic condition in cardiac myocytes. YM-255693 was, therefore, tested in ischemia-induced arrhythmia models in vitro and in vivo. YM-255693 prevented coronary artery (LAD) ligation-induced ventricular arrhythmias in Langendorff-perfused rat hearts. Moreover, YM-255693 at 30mg/kg i. v. inhibited LAD ligation-induced ventricular arrhythmias in anesthetized rats. Our data suggest that VRAC contributes to the occurrence of ventricular arrhythmias, and that VRAC inhibitors such as YM-255693 constitute a new class of antiarrhythmic agents.</description><identifier>ISSN: 1347-8613</identifier><language>jpn</language><publisher>The Japanese Pharmacological Society</publisher><ispartof>Journal of Pharmacological Sciences, 2004, Vol.94 (suppl.1), p.108-108</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024</link.rule.ids></links><search><creatorcontrib>Hiroshi Shibata</creatorcontrib><creatorcontrib>Tomo-oki Satoh</creatorcontrib><creatorcontrib>Tohru Ugawa</creatorcontrib><creatorcontrib>Hiroko Yanai-Inamura</creatorcontrib><creatorcontrib>Noriyuki Masuda</creatorcontrib><creatorcontrib>Wataru Uchida</creatorcontrib><creatorcontrib>Keiji Miyata</creatorcontrib><creatorcontrib>Research Coordination Dep</creatorcontrib><creatorcontrib>Inst. for Drug Discovery Res</creatorcontrib><creatorcontrib>Ltd</creatorcontrib><creatorcontrib>Pharmacology Lab</creatorcontrib><creatorcontrib>Yamanouchi Pharmaceutical Co</creatorcontrib><creatorcontrib>Faculty of Agriculture</creatorcontrib><creatorcontrib>Okayama Univ. The Grad. School of Natural Science and Technology</creatorcontrib><creatorcontrib>Okayama Univ</creatorcontrib><title>O-20137 A novel volume-regulated anion channel inhibitor, YM-255693, prevents ischemia-induced arrhythmia in rats</title><title>Journal of Pharmacological Sciences</title><description>The aim of this study is to evaluate a contribution of the volume-regulated anion channel (VRAC) to ischemia-induced arrhythmia. YM-255693, an isothiazol derivative, inhibited VRAC in hypotonic stimulus-induced taurine efflux assay in HeLa cells (IC50=0. 83μM) more potently than often-used VRAC blocker, DIDS or NPPB. In contrast, YM-255693 weakly inhibited Ca2+-activated and cAMP-activated Cl- channel in HTC cells (IC50=5. 9μM) and T84 cells (40% at 30μM), respectively. VRAC is reported to be involved in control of membrane potential in the ischemic condition in cardiac myocytes. YM-255693 was, therefore, tested in ischemia-induced arrhythmia models in vitro and in vivo. YM-255693 prevented coronary artery (LAD) ligation-induced ventricular arrhythmias in Langendorff-perfused rat hearts. Moreover, YM-255693 at 30mg/kg i. v. inhibited LAD ligation-induced ventricular arrhythmias in anesthetized rats. Our data suggest that VRAC contributes to the occurrence of ventricular arrhythmias, and that VRAC inhibitors such as YM-255693 constitute a new class of antiarrhythmic agents.</description><issn>1347-8613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqtjEtOxDAQRLMAiRHMHXyAsdS283GWCPHZIDZsWFkep2fSyGmDnUTi9gTEEdhUSfX06qLaKVN30rbKXFX7UugIoK3Wqml21eeL1KBMJ24FpxWjWFNcJpQZz0v0Mw7CMyUWYfTMGyYe6Uhzygfx9ix107S9OYiPjCvyXASVMOJEXhIPS_ixcx6_5nGbNlVkP5eb6vLkY8H9X19Xjw_3r3dPcsKBgo-JIzG697Rk3rgLp7YEQnYaoHYAfV2UM712oMD-hoLOgrXm_56-AayNXmg</recordid><startdate>2004</startdate><enddate>2004</enddate><creator>Hiroshi Shibata</creator><creator>Tomo-oki Satoh</creator><creator>Tohru Ugawa</creator><creator>Hiroko Yanai-Inamura</creator><creator>Noriyuki Masuda</creator><creator>Wataru Uchida</creator><creator>Keiji Miyata</creator><general>The Japanese Pharmacological Society</general><scope/></search><sort><creationdate>2004</creationdate><title>O-20137 A novel volume-regulated anion channel inhibitor, YM-255693, prevents ischemia-induced arrhythmia in rats</title><author>Hiroshi Shibata ; Tomo-oki Satoh ; Tohru Ugawa ; Hiroko Yanai-Inamura ; Noriyuki Masuda ; Wataru Uchida ; Keiji Miyata</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-medicalonline_journals_cf6scien_2004_0094s1_392_0108_010810780883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>2004</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hiroshi Shibata</creatorcontrib><creatorcontrib>Tomo-oki Satoh</creatorcontrib><creatorcontrib>Tohru Ugawa</creatorcontrib><creatorcontrib>Hiroko Yanai-Inamura</creatorcontrib><creatorcontrib>Noriyuki Masuda</creatorcontrib><creatorcontrib>Wataru Uchida</creatorcontrib><creatorcontrib>Keiji Miyata</creatorcontrib><creatorcontrib>Research Coordination Dep</creatorcontrib><creatorcontrib>Inst. for Drug Discovery Res</creatorcontrib><creatorcontrib>Ltd</creatorcontrib><creatorcontrib>Pharmacology Lab</creatorcontrib><creatorcontrib>Yamanouchi Pharmaceutical Co</creatorcontrib><creatorcontrib>Faculty of Agriculture</creatorcontrib><creatorcontrib>Okayama Univ. The Grad. School of Natural Science and Technology</creatorcontrib><creatorcontrib>Okayama Univ</creatorcontrib><jtitle>Journal of Pharmacological Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hiroshi Shibata</au><au>Tomo-oki Satoh</au><au>Tohru Ugawa</au><au>Hiroko Yanai-Inamura</au><au>Noriyuki Masuda</au><au>Wataru Uchida</au><au>Keiji Miyata</au><aucorp>Research Coordination Dep</aucorp><aucorp>Inst. for Drug Discovery Res</aucorp><aucorp>Ltd</aucorp><aucorp>Pharmacology Lab</aucorp><aucorp>Yamanouchi Pharmaceutical Co</aucorp><aucorp>Faculty of Agriculture</aucorp><aucorp>Okayama Univ. The Grad. School of Natural Science and Technology</aucorp><aucorp>Okayama Univ</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>O-20137 A novel volume-regulated anion channel inhibitor, YM-255693, prevents ischemia-induced arrhythmia in rats</atitle><jtitle>Journal of Pharmacological Sciences</jtitle><date>2004</date><risdate>2004</risdate><volume>94</volume><issue>suppl.1</issue><spage>108</spage><epage>108</epage><pages>108-108</pages><issn>1347-8613</issn><abstract>The aim of this study is to evaluate a contribution of the volume-regulated anion channel (VRAC) to ischemia-induced arrhythmia. YM-255693, an isothiazol derivative, inhibited VRAC in hypotonic stimulus-induced taurine efflux assay in HeLa cells (IC50=0. 83μM) more potently than often-used VRAC blocker, DIDS or NPPB. In contrast, YM-255693 weakly inhibited Ca2+-activated and cAMP-activated Cl- channel in HTC cells (IC50=5. 9μM) and T84 cells (40% at 30μM), respectively. VRAC is reported to be involved in control of membrane potential in the ischemic condition in cardiac myocytes. YM-255693 was, therefore, tested in ischemia-induced arrhythmia models in vitro and in vivo. YM-255693 prevented coronary artery (LAD) ligation-induced ventricular arrhythmias in Langendorff-perfused rat hearts. Moreover, YM-255693 at 30mg/kg i. v. inhibited LAD ligation-induced ventricular arrhythmias in anesthetized rats. Our data suggest that VRAC contributes to the occurrence of ventricular arrhythmias, and that VRAC inhibitors such as YM-255693 constitute a new class of antiarrhythmic agents.</abstract><pub>The Japanese Pharmacological Society</pub></addata></record>
fulltext fulltext
identifier ISSN: 1347-8613
ispartof Journal of Pharmacological Sciences, 2004, Vol.94 (suppl.1), p.108-108
issn 1347-8613
language jpn
recordid cdi_medicalonline_journals_cf6scien_2004_0094s1_392_0108_01081078088
source ScienceDirect®
title O-20137 A novel volume-regulated anion channel inhibitor, YM-255693, prevents ischemia-induced arrhythmia in rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T07%3A14%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-medicalonline&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=O-20137%20A%20novel%20volume-regulated%20anion%20channel%20inhibitor,%20YM-255693,%20prevents%20ischemia-induced%20arrhythmia%20in%20rats&rft.jtitle=Journal%20of%20Pharmacological%20Sciences&rft.au=Hiroshi%20Shibata&rft.aucorp=Research%20Coordination%20Dep&rft.date=2004&rft.volume=94&rft.issue=suppl.1&rft.spage=108&rft.epage=108&rft.pages=108-108&rft.issn=1347-8613&rft_id=info:doi/&rft_dat=%3Cmedicalonline%3Ecf6scien_2004_0094s1_392_0108_01081078088%3C/medicalonline%3E%3Cgrp_id%3Ecdi_FETCH-medicalonline_journals_cf6scien_2004_0094s1_392_0108_010810780883%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true